DOCSLIB.ORG

The Post-Polio Syndrome, Epidemiological Characteristics and Risk Factors in Algeria

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Post-Polio Syndrome, Epidemiological Characteristics and Risk Factors in Algeria Central JSM Physical Medicine and Rehabilitation Bringing Excellence in Open Access Research Article *Corresponding author Zouhir Boukara, MPR Blida, Service MPR CHU, Sidi Bel Abbes University DJILALI Liabes, Algeria, Email: The Post-Polio Syndrome, Submitted: 31 October 2016 Epidemiological Characteristics Accepted: 17 November 2016 Published: 18 November 2016 Copyright and Risk Factors in Algeria © 2016 Boukara et al. Boukara Z1*, Nouar AC1, Bedjaoui M2, Arbaoui S1, Benzaoui S1, OPEN ACCESS Lahmer A3, Bouamra A4, Besaad A5, and Benazouz F5 Keywords 1 Service MRP Blida, University of Blida SAAD Dahleb, Algeria • Poliomyelitis 2 Service MPR CHU, Sidi Bel Abbes University DJILALI Liabes, Algeria • PPS 3 Service of Epidemiologie CHU, Sidi Bel Abbes University DJILALI Liabes, Algeria • Fatigue 4 Service of Epidemiologie CHU, Sidi Bel Abbes University SAAD Dahleb, Algeria • Cold intolerance 5 Faculty Sciences Biology, University nature SAAD Dahleb Blida, Algeria • Obesity Abstract 1.1. Introduction: The post-polio syndrome (PPS) is a clinical entity, appears at least 15 years after the acute phase of polio in the frequency of this pathology, it is over 20%. The management of the SPP remains outside any regimen well lit and codified. Our goal in this work is to identify the epidemiological including identifying risk factors. 1.2. Patients and methods: This is a descriptive study based on historical cohort of patients carried over from 2010 to 2013, made on 104 patients with acute anterior poliomyelitis sequelae. A listing review was developed with items in search of symptoms characterizing the post-polio syndrome (pain, fatigue and new muscle weakness ...). 1.3. Results: The prevalence of PPS in our cohort is 46. 31% of PPS-patients have an average grade. Sex is not a risk factor. The important age group is that of 40-49 years, There remains no age in our cohort represents a significant impact to the PPS. In our cohort of polio the risk of having a PPS is almost tripled to an age in acute> 4 years with a significant difference. Obesity is present in 29% of PPS patients, and obesity is a risk factor for polio patients. Most PPS patients have monoplegia on the lower limbs. Functional assessment of the scale “MIF” Overall, in our PPS patients before onset muscle news, and at recruitment, rocking higher scores to lower scores but without statistical significance. The pain is almost present. The cold intolerance symptom, very present 90% especially in the lower limbs. We do not find significant figures related to cognition disorders, namely memory disorders. 1.4. Discussion: In our study, the prevalence of PPS is 46% (48 SPP / 104 Polios). This impact, more or less, high in Algeria, is probably related to a non- alerted medical community, disregarding. The age of onset of polio in our PPS population (Algeria) is 1 to 3 years. This, would it be related to the type of attenuated vaccine used in Algeria (oral). The PPS age of onset is 42 years, is due to inadequate physical activity, or in connection with a bad assumption. A new muscle weakness is a critical symptom; our results are consistent with other series. The risk of SPP, among polio patients is multiplied by five when obese. The prevalence of pain in our sample is around 89.58%, which leads us to believe it is very present in PPS patients. We believe that this high rate may be related to a total disregard of the rules of hygiene of this syndrome. Intolerance to cold was found in our PPS patients, and much more than in other series. It seems that this is a particulate of our population 1.5. Conclusion: The PPS is a clinical entity in itself, Think of the post-polio syndrome before: fatigue, new muscle weakness, muscle pain and / or joint. Seizing the risk factors that seem paramount. A study on the specific care needs of PPS patients is more than necessary for these patients. INTRODUCTION have been proposed by LS Halstead, validated by “the European Federation of Neurological Societies “. As to the frequency of The post-polio syndrome (PPS) is a clinical entity, made of this disease, neurological rather, it varies from 20% to 60% new symptoms (new paresis, fatigue, pain, muscle atrophy and among polio survivors patients [1,2]. The diagnosis of post-polio cold intolerance) that appear remote, a few years of infection syndrome is essentially disposal, which must remove all medical or surgical causes may be the source of this group of symptoms international conference in 1984 at the Warm Springs Institute with poliovirus. This name was used for the first time in the for Rehabilitation in Georgia. frequency of this disease, neurological rather, it varies from 20% In fact, at least 15 years of evolution after a poliovirus tothat 60% are notamong specific polio to survivors this particular patients clinical [6-8]. entity The [3-5]. management As to the infection, new clinical signs appear. Charcot, in 1875 highlights a recurrence, which is made by muscle weakness, and it was Emerging drug treatments and topical show a slight pain relief, not until 1985, the diagnostic criteria for post-polio syndrome qualityof the PPSof life remains and muscle outside strength. any regimen well-lit and codified. Cite this article: Boukara Z, Nouar AC, Bedjaoui M, Arbaoui S, Benzaoui S, et al. (2016) The Post-Polio Syndrome, Epidemiological Characteristics and Risk Factors in Algeria. JSM Physical Med Rehabil 1(1): 1001. Boukara et al. (2016) Email: Central Bringing Excellence in Open Access The physical medicine and rehabilitation is promising status paralytic. for these patients, more when combined with drug therapy, The type of equipment worn by the patient. particularly intravenous immunoglobulin’s to date used in clinical trials, and other future drug [9,10]. Algeria is also well-known by •Component 3 acute anterior poliomyelitis epidemics in the sixties. There were · General weakness: PPS own and clinical loss of data function. to know : ). Their support was often · done4,000 inpolio the survivorshospital the between time of the referral, years 1963Tixeraine and 1996Hospital (Site: in · Algiers.http://www.ands.dz/insp/pev.htm it should be noted that the most serious cases affected in Pain: its type, mode, time delays, and location. members. the sixties, were transferred for care in France. As for post-polio Muscle weakness: the time of onset, muscles and affected syndrome, unfortunately, there is no epidemiological evidence · Assessment of the functional state by the Scale MIF or research on the reality of this disease in our country that can (transfer deals mobility locomotion in his items). guide practitioners in their daily newspapers. This clinical entity · has a strong socio-professional impact in particular on the quality through the Borg Scale and Scale Pichot and the notion of walking of life; our goal in this work is to identify the epidemiological perimeterFatigue: before the the timeonset of time, onset, and typenow. and its measurement including identifying risk factors for Prevention of this syndrome. · Seeking cold intolerance, insomnia, depression and PATIENTS AND METHODS cognitive impairment including memory. RESULTS kind, made of 104 patients with acute anterior poliomyelitis (AAP)This sequelae is a scoping exposed study to over submit a period a clinical from 2010 entity to called2013 cohort ‘post- The prevalence of PPS in our cohort of polio patients is polio syndrome’, this study is based prospective descriptive 46%. According to the criteria of Halstead muscle weakness is patient history. the main symptom associated with at least two other criteria to A listing review was developed with items in search of confirm PPS. This study determines the association (DLR + FM and muscle weakness news…). + FTG AMY + + IF) as PPS criteria characterizing our population symptoms characterizing the post-polio syndrome (pain, fatigue patients have an average grade, and only 10% were able to go Pain rating scales (VAS), muscle strength (Scale Muscular towith university a prevalence level, of 50% 73% are (restriction married with combinations). family responsibilities, 31% of PPS Testing), fatigue and 60% do not have a job. The male sex is predominant with a rate of 52.08%. Note that the risk of occurrence of the PPS, in (Borg Scale and Scale Pichot) as well as the quality of life and function (Scale of functional independence Measure MIF) were used during the study. Patients were examined at the consultation our cohort of polio is almost doubled, any time we do not find a as available with the maximum of information gathering within significant§ The difference. important age group is that of 40-49 years. There the scope of items designed in established forms. the PPS. In need of electrophysiological explorations, radiological, and remains no age in our cohort represents a significant impact to biological are required to identify the various signs to identify. § The age in the acute phase in our post-polio patients of polio the risk of having a PPS is almost tripled to an age in acute> The· parametersComponent and variables 1 used in our study on the PPS are: 1-3 years is strongly present in 71.5%. Any time in our cohort of the person with AAP sequelae, which are collected through : Marital Status and characteristics of an interview by a single practitioner through a questionnaire 4 years with a significant difference. PPS: Post-polio syndrome FM: New muscle weakness DLR: with:Age· Datein year of recruitmentaudited on an and identity File No., card. telephone coordinated painThe FTG: average fatigue BMIAMY: was atrophy estimated IF: cold at intolerance26.89 ± 5.47, obesity is and exact address. The study of risk factors found that obese polio victims at risk · Marital status and number of children in care.
Load more

Recommended publications
  • Approach to a Patient with Hemiplegia and Monoplegia
    CHAPTER Approach to a Patient with Hemiplegia and Monoplegia 27 Sudhir Kumar, Subhash Kaul INTRODUCTION 4. Injury to multiple cervical nerve roots. Monoplegia and hemiplegia are common neurological 5. Functional or psychogenic. symptoms in patients presenting to the emergency department as well as outpatient department. Insidious onset, gradually progressive monoplegia affecting lower limb can be caused by the following Monoplegia refers to weakness of one limb (either arm or conditions: leg) and hemiplegia refers to weakness of one arm and leg on the same side of body (either left or right side). 1. Tumor of the contralateral frontal lobe. There are a variety of underlying causes for monoplegia 2. Tumor of spinal cord at thoracic or lumbar level. and hemiplegia. The causes differ in different age groups. 3. Chronic infection of brain (frontal lobe) or spinal The causes also differ depending on the onset, progression cord (thoracic or lumbar level), such as tuberculous. and duration of weakness. Therefore, one needs to adopt a systematic approach during history taking and 4. Lumbosacral-plexopathy, due to diabetes mellitus. examination in order to arrive at the correct diagnosis. Insidious onset, gradually progressive monoplegia, Appropriate investigations after these would confirm the affecting upper limb, can be caused by one of the following diagnosis. conditions: The aim of this chapter is to systematically look at the 1. Tumor of the contralateral parietal lobe. differential diagnosis of monoplegia and hemiplegia and outline the approach needed to pinpoint the exact 2. Compressive lesion (tumor, large disc, etc) in underlying cause. cervical cord region. 3. Chronic infection of the brain (parietal lobe) or APPROACH TO THE DIAGNOSIS OF MONOPLEGIA spinal cord (cervical region), such as tuberculous.
    [Show full text]
  • Myelopathy—Paresis and Paralysis in Cats
    Myelopathy—Paresis and Paralysis in Cats (Disorder of the Spinal Cord Leading to Weakness and Paralysis in Cats) Basics OVERVIEW • “Myelopathy”—any disorder or disease affecting the spinal cord; a myelopathy can cause weakness or partial paralysis (known as “paresis”) or complete loss of voluntary movements (known as “paralysis”) • Paresis or paralysis may affect all four limbs (known as “tetraparesis” or “tetraplegia,” respectively), may affect only the rear legs (known as “paraparesis” or “paraplegia,” respectively), the front and rear leg on the same side (known as “hemiparesis” or “hemiplegia,” respectively) or only one limb (known as “monoparesis” or “monoplegia,” respectively) • Paresis and paralysis also can be caused by disorders of the nerves and/or muscles to the legs (known as “peripheral neuromuscular disorders”) • The spine is composed of multiple bones with disks (intervertebral disks) located in between adjacent bones (vertebrae); the disks act as shock absorbers and allow movement of the spine; the vertebrae are named according to their location—cervical vertebrae are located in the neck and are numbered as cervical vertebrae one through seven or C1–C7; thoracic vertebrae are located from the area of the shoulders to the end of the ribs and are numbered as thoracic vertebrae one through thirteen or T1–T13; lumbar vertebrae start at the end of the ribs and continue to the pelvis and are numbered as lumbar vertebrae one through seven or L1–L7; the remaining vertebrae are the sacral and coccygeal (tail) vertebrae • The brain
    [Show full text]
  • Absence of Neurobehavioral Disturbance in a Focal Lesion of the Left Paracentral Lobule
    Behavioural Neurology (1992), 5,189-191 ICASE REPORTI Absence of neurobehavioral disturbance in a focal lesion of the left paracentral lobule T. Imamura and K. Tsuburaya Department of Neurology, Tohoku Kohseinenkin Hospital, Sendai, Japan Correspondence to: T. Imamura, Department of Neurology, Institute of Brain Diseases, Tohoku University School of Medicine, 1-1, Seiryo-machi, Aoba-Ku, Sendai 980, Japan The case of a right-handed woman with an infarcation confined to the left paracentral lobule and sparing the supplementary motor area (SMA) is reported. She presented with a right leg monoplegia and displayed no mutism. The absence of any associ­ ated neurobehavioral disturbances (mutism, forced grasping, reduced spontaneous arm activity or aphasia raises the possi­ bility that the left SMA has discrete neurobehavioral functions. Keywords: Medial frontal lobe - Precentral gyrus - Supplementary motor area - Transcortical motor aphasia INTRODUCTION Various kinds of neurobehavioral disturbances associated medial part of the left precentral gyrus, which is adjacent with left medial frontal lesions involving the supplemen­ to the SMA, to evaluate its possible neurobehavioral tary motor area (SMA) have been reported. Aphasia due to functions. damage of the left medial frontal lobe is characterized by an initial period of mutism followed by a stage of CASE REPORT decreased verbal output and spontaneous initiation with normal articulation (Stuss and Benson, 1986). Forced A 73-year-old right-handed woman with a history of grasping, compulsive manipulation of tools and decreased hypertension and diabetes mellitus suddenly developed a spontaneous limb movements have also been described gait disturbance. On examination, 24 h later, she was alert (Wise, 1984; Feinberg et al., 1992).
    [Show full text]
  • ICD9 & ICD10 Neuromuscular Codes
    ICD-9-CM and ICD-10-CM NEUROMUSCULAR DIAGNOSIS CODES ICD-9-CM ICD-10-CM Focal Neuropathy Mononeuropathy G56.00 Carpal tunnel syndrome, unspecified Carpal tunnel syndrome 354.00 G56.00 upper limb Other lesions of median nerve, Other median nerve lesion 354.10 G56.10 unspecified upper limb Lesion of ulnar nerve, unspecified Lesion of ulnar nerve 354.20 G56.20 upper limb Lesion of radial nerve, unspecified Lesion of radial nerve 354.30 G56.30 upper limb Lesion of sciatic nerve, unspecified Sciatic nerve lesion (Piriformis syndrome) 355.00 G57.00 lower limb Meralgia paresthetica, unspecified Meralgia paresthetica 355.10 G57.10 lower limb Lesion of lateral popiteal nerve, Peroneal nerve (lesion of lateral popiteal nerve) 355.30 G57.30 unspecified lower limb Tarsal tunnel syndrome, unspecified Tarsal tunnel syndrome 355.50 G57.50 lower limb Plexus Brachial plexus lesion 353.00 Brachial plexus disorders G54.0 Brachial neuralgia (or radiculitis NOS) 723.40 Radiculopathy, cervical region M54.12 Radiculopathy, cervicothoracic region M54.13 Thoracic outlet syndrome (Thoracic root Thoracic root disorders, not elsewhere 353.00 G54.3 lesions, not elsewhere classified) classified Lumbosacral plexus lesion 353.10 Lumbosacral plexus disorders G54.1 Neuralgic amyotrophy 353.50 Neuralgic amyotrophy G54.5 Root Cervical radiculopathy (Intervertebral disc Cervical disc disorder with myelopathy, 722.71 M50.00 disorder with myelopathy, cervical region) unspecified cervical region Lumbosacral root lesions (Degeneration of Other intervertebral disc degeneration,
    [Show full text]
  • Hemiballismus: /Etiology and Surgical Treatment by Russell Meyers, Donald B
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.13.2.115 on 1 May 1950. Downloaded from J. Neurol. Neurosurg. Psychiat., 1950, 13, 115. HEMIBALLISMUS: /ETIOLOGY AND SURGICAL TREATMENT BY RUSSELL MEYERS, DONALD B. SWEENEY, and JESS T. SCHWIDDE From the Division of Neurosurgery, State University of Iowa, College ofMedicine, Iowa City, Iowa Hemiballismus is a relatively uncommon hyper- 1949; Whittier). A few instances are on record in kinesia characterized by vigorous, extensive, and which the disorder has run an extended chronic rapidly executed, non-patterned, seemingly pur- course (Touche, 1901 ; Marcus and Sjogren, 1938), poseless movements involving one side of the body. while in one case reported by Lea-Plaza and Uiberall The movements are almost unceasing during the (1945) the abnormal movements are said to have waking state and, as with other hyperkinesias con- ceased spontaneously after seven weeks. Hemi- sidered to be of extrapyramidal origin, they cease ballismus has also been known to cease following during sleep. the supervention of a haemorrhagic ictus. Clinical Aspects Terminology.-There appears to be among writers on this subject no agreement regarding the precise Cases are on record (Whittier, 1947) in which the Protected by copyright. abnormal movements have been confined to a single features of the clinical phenomena to which the limb (" monoballismus ") or to both limbs of both term hemiballismus may properly be applied. sides (" biballismus ") (Martin and Alcock, 1934; Various authors have credited Kussmaul and Fischer von Santha, 1932). In a majority of recorded (1911) with introducing the term hemiballismus to instances, however, the face, neck, and trunk as well signify the flinging or flipping character of the limb as the limbs appear to have been involved.
    [Show full text]
  • HCC Risk Adjustment Terminology: • HCC • CCV • AHA • RAF Score / Risk Score What Is Risk Adjustment?
    HCC Risk Adjustment Terminology: • HCC • CCV • AHA • RAF Score / Risk Score What is Risk Adjustment? Who? What? Why? How? Redistributes Actuarial risk funds from plans Medicare To protect against based on with lower-risk Advantage Plans, adverse selection enrollees’ enrollees to plans Health Insurance and risk selection individual risk with higher-risk Exchanges, scores others enrollees RAF Calculation Demographic Health RAF Information StatusHealth Status Score Risk Score Higher risk scores represent members with a higher disease burden resulting in appropriately higher reimbursement. Lower risk scores represent a healthier population, but may also be due to: • Poor chart documentation • Poor diagnosis coding Why is this important? • Results in appropriate reimbursement • Augments the overall patient evaluation process • Allows us to stratify patients by risk • Metric for considering panel size, productivity, access, and coding education efforts Current Scope: Attributed Downside Plan Gain Share Lives Risk NGACO 24,876 80%/6.5 80%/6.5 91.5%- MCW 3,785 100% 100.65% Healthy 91.5%- 4,163 100% Saver 100.65% MA 16,561 50% TBD Current State: HCP-LAN APM Framework Category 3A: 83% Category 3B: 17% FFS APM HCC Risk Model • Diagnosis codes with RAF values are grouped into Condition Categories. • Diseases within a Condition Category are clinically related and are similar in respect to cost patterns. HCC Description Applicable Diagnoses to HCC Category RAF 111 Chronic Obstructive COPD Emphysema 0.346 Pulmonary Disease Chronic Bronchitis 108 Vascular Disease Atherosclerosis (of native or PVD 0.299 bypass grafts with or without Phlebitis and Thrombophlebitis complications [rest pain, (acute or chronic) claudication, etc]) Embolism of Veins (acute or Aortic Aneurysm chronic) (nonruptured) Diabetic Peripheral Angiopathy Arterial Aneurysm • There are 79 identified Condition Categories in 2018.
    [Show full text]
  • Assessment of Acute Motor Deficit in the Pediatric Emergency Room
    J Pediatr (Rio J). 2017;93(s1):26---35 www.jped.com.br REVIEW ARTICLE Assessment of acute motor deficit in the pediatric ଝ emergency room a,∗ b a Marcio Moacyr Vasconcelos , Luciana G.A. Vasconcelos , Adriana Rocha Brito a Universidade Federal Fluminense (UFF), Hospital Universitário Antônio Pedro, Departamento Materno Infantil, Niterói, RJ, Brazil b Associac¸ão Brasileira Beneficente de Reabilitac¸ão (ABBR), Divisão de Pediatria, Rio de Janeiro, RJ, Brazil Received 21 May 2017; accepted 28 May 2017 Available online 27 July 2017 KEYWORDS Abstract Objectives: This review article aimed to present a clinical approach, emphasizing the diagnostic Acute weakness; investigation, to children and adolescents who present in the emergency room with acute-onset Motor deficit; Guillain---Barré muscle weakness. syndrome; Sources: A systematic search was performed in PubMed database during April and May 2017, using the following search terms in various combinations: ‘‘acute,’’ ‘‘weakness,’’ ‘‘motor Transverse myelitis; Child deficit,’’ ‘‘flaccid paralysis,’’ ‘‘child,’’ ‘‘pediatric,’’ and ‘‘emergency’’. The articles chosen for this review were published over the past ten years, from 1997 through 2017. This study assessed the pediatric age range, from 0 to 18 years. Summary of the data: Acute motor deficit is a fairly common presentation in the pedi- atric emergency room. Patients may be categorized as having localized or diffuse motor impairment, and a precise description of clinical features is essential in order to allow a complete differential diagnosis. The two most common causes of acute flaccid paralysis in the pediatric emergency room are Guillain---Barré syndrome and transverse myeli- tis; notwithstanding, other etiologies should be considered, such as acute disseminated encephalomyelitis, infectious myelitis, myasthenia gravis, stroke, alternating hemiplegia of childhood, periodic paralyses, brainstem encephalitis, and functional muscle weakness.
    [Show full text]
  • Cerebrovascular Accident (CVA) ICD-10-CM Clinical Overview
    Cerebrovascular accident (CVA) ICD-10-CM Clinical overview Definition Some causes of hemorrhagic CVA A cerebrovascular accident, also known as a stroke, is an . Untreated or uncontrolled high blood pressure interruption or disruption of blood flow to the brain. Traumatic head and neck injuries When blood flow to an area of the brain stops, oxygen . Surgeries involving blood vessels of head and neck and nutrients cannot get to that area of the brain, and . Blood-thinning medications brain cells begin to die, resulting in permanent damage. Brain aneurysms (weak spots in walls of blood vessels in the brain) and other abnormalities of blood vessels Types in and around the brain . Ischemic: This type is usually caused by a blood clot . Bleeding disorders that blocks a blood vessel (artery) that supplies . Brain tumors oxygen-rich blood to the brain. Liver disease, which is associated with increased o Thrombotic stroke: A blood clot forms inside an bleeding in general artery that supplies blood to the brain, blocking blood flow. Risk factors o Embolic stroke: A blood clot forms in a vessel in . High blood pressure/hypertension another part of the body and then travels to and . Diabetes blocks a blood vessel in the brain. Obesity o Other types of ischemic stroke include very low . High cholesterol blood pressure or narrowing or tears in the lining . Cardiovascular disease of one of the blood vessels that carry blood to . Alcoholism the brain (i.e., carotid arteries), all of which . Smoking decrease blood flow to the brain. Age (older than 55) . Hemorrhagic: A blood vessel within the brain .
    [Show full text]
  • BOTOX® Billing & Coding for Neurorehab
    STREAMLINE BOTOX® Billing & Coding for NeuroRehab Cervical Dystonia, Blepharospasm, and Focal Spasticity Indications Spasticity: Upper Limb Spasticity BOTOX® for injection is indicated for the treatment of upper limb spasticity in adult patients to decrease the severity of increased muscle tone in elbow, wrist, finger, and thumb flexors (biceps, flexor carpi radialis, flexor carpi ulnaris, flexor digitorum profundus, flexor digitorum sublimis, adductor pollicis, and flexor pollicis longus). Lower Limb Spasticity BOTOX® is indicated for the treatment of lower limb spasticity in adult patients to decrease the severity of increased muscle tone in ankle and toe flexors (gastrocnemius, soleus, tibialis posterior, flexor hallucis longus, and flexor digitorum longus). Important Limitations Safety and effectiveness of BOTOX® have not been established for the treatment of other upper or lower limb muscle groups or for the treatment of spasticity in pediatric patients under age 18 years. BOTOX® has not been shown to improve upper extremity functional abilities, or range of motion at a joint affected by a fixed contracture. Treatment with BOTOX® is not intended to substitute for usual standard of care rehabilitation regimens. Cervical Dystonia BOTOX® is indicated for the treatment of adults with Cervical Dystonia to reduce the severity of abnormal head position and neck pain associated with Cervical Dystonia. Blepharospasm BOTOX® is indicated for the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in patients 12 years of age and above. IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects.
    [Show full text]
  • Monoplegia and Paresthesia As Rare Presentations of Type B Aortic Dissection
    Tzu Chi Medical Journal 23 (2011) 142e144 Contents lists available at ScienceDirect Tzu Chi Medical Journal journal homepage: www.tzuchimedjnl.com Case Report Monoplegia and paresthesia as rare presentations of type B aortic dissection Cheng-Ta Hsieh a,b, Tzu-Tsao Chung b, Ming-Ying Liu b,* a Department of Neurosurgery, Sijhih Cathay General Hospital, New Taipei, Taiwan b Department of Neurological Surgery, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan article info abstract Article history: Aortic dissection is a cardiovascular emergency, and the management remains a challenge for physicians Received 19 April 2011 because of the abrupt symptoms and rapid process. Acute neurological complications caused by Received in revised form descending aortic dissection, especially monoplegia, are rarely manifested. Herein, we present a 24-year- 17 May 2011 old man with Type B aortic dissection with acute onset of abdominal pain, accompanied by weakness and Accepted 20 June 2011 numbness only in the right lower extremity. After injection of contrast medium, computed tomography of the thorax and abdomen confirmed a diagnosis of Type B aortic dissection with the false lumen from Key words: the suprarenal descending aorta to the right common iliac artery. The monoplegia and paresthesia in the Aortic dissection Monoplegia right lower extremity may have resulted from occlusion of the right common iliac artery because of the fl Paresthesia intimal ap. The detailed physical examination with absent pulsation of the right dorsalis pedis artery and right femoral artery, isolated low blood pressure and low motor neuron dysfunction of the right lower extremity, and abdominal/chest computed tomography were the key points for the correct diagnosis in our patient.
    [Show full text]
  • Peripheral Nervous System Complications of Infectious Diseases
    Peripheral Nervous System Complications of Infectious Diseases A. Arturo Leis, MD John J. Halperin, MD Taylor B. Harrison, MD Dianna Quan, MD AANEM 59th Annual Meeting Orlando, Florida Copyright © October 2012 American Association of Neuromuscular & Electrodiagnostic Medicine 2621 Superior Drive NW Rochester, MN 55901 Printed by Johnson Printing Company, Inc. 1 Dr. Quan has indicated that her material references an “off-label” use of a commercial product. Please be aware that some of the medical devices or pharmaceuticals discussed in this handout may not be cleared by the FDA or cleared by the FDA for the specific use described by the authors and are “off-label” (i.e., a use not described on the product’s label). “Off-label” devices or pharmaceuticals may be used if, in the judgment of the treating physician, such use is medically indicated to treat a patient’s condition. Information regarding the FDA clearance status of a particular device or pharmaceutical may be obtained by reading the product’s package labeling, by contacting a sales representative or legal counsel of the manufacturer of the device or pharmaceutical, or by contacting the FDA at 1-800-638-2041. 2 Peripheral Nervous System Complications of Infectious Diseases Table of Contents Course Committees & Course Objectives 4 Faculty 5 Neuromuscular Manifestations of West Nile and Polio Virus Infection 7 A. Arturo Leis, MD Peripheral Nervous System Complications of Neuroborreliosis 15 John J. Halperin, MD Polyneuropathies Associated With Infectious Disease 21 Taylor B. Harrison, MD Varicella Zoster Virus and Postherpetic Neuralgia: A New Era? 31 Dianna Quan, MD CME Questions 35 No one involved in the planning of this CME activity had any relevant financial relationships to disclose.
    [Show full text]
  • Study Protocol - a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study in Subjects with Restless Legs Syndrome
    Sponsor: API ISN/Protocol <8825-CL-0101> ‐ CONFIDENTIAL ‐ Gabapentin Enacarbil Post-marketing Clinical Study Protocol - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study in Subjects With Restless Legs Syndrome - ISN/Protocol 8825-CL-0101 Version 3.0 13 January 2017 (Translation from Japanese) Sponsor: Astellas Pharma Inc.(API) 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo This document is the property of the Sponsor. Unpublished information in this document must not be disclosed without prior written agreement of the Sponsor. 13 January 2017 Astellas Page 1 of 105 Sponsor: API ISN/Protocol <8825-CL-0101> ‐ CONFIDENTIAL ‐ Table of Contents I SIGNATURE ······················································································· 8 II CONTACT DETAILS OF KEY SPONSOR’S PERSONNEL ···························· 9 III LIST OF ABBREVIATIONS AND DEFINITION OF KEY TERM ··················· 10 IV SYNOPSIS·························································································· 13 V FLOW CHART AND SCHEDULE OF ASSESSMENTS································· 20 1 INTRODUCTION ················································································ 24 1.1 Background···················································································· 24 1.2 Nonclinical and Clinical Data ······························································· 25 1.2.1 Nonclinical Data ········································································ 25 1.2.2 Clinical Data·············································································
    [Show full text]